A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Chronic Hepatitis B
Interventions
DRUG

Tenofovir disoproxil fumarate

300-mg tablet (marketed formulation) taken orally once daily

Trial Locations (21)

10013

New York

10038

New York

11219

Brooklyn

11355

Flushing

19107

Philadelphia

20707

Laurel

20902

Silver Spring

21234

Baltimore

22030

Fairfax

22044

Falls Church

90057

Los Angeles

91745

Hacienda Heights

91754

Monterey Park

92708

Fountain Valley

94040

Mountain View

94304

Palo Alto

94609

Oakland

95128

San Jose

98004

Bellevue

06518

Hamden

07631

Englewood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY